Commodore Capital LP has filed its 13F form on August 14, 2024 for Q2 2024 where it was disclosed a total value porftolio of $1.12 Billion distributed in 35 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Merus N.V. with a value of $189M, Nuvalent, Inc. with a value of $113M, Xenon Pharmaceuticals Inc. with a value of $107M, Vaxcyte, Inc. with a value of $98.5M, and Vera Therapeutics, Inc. with a value of $89.5M.

Examining the 13F form we can see an decrease of $42.5M in the current position value, from $1.16B to 1.12B.

Commodore Capital LP is based out at New York, NY

Below you can find more details about Commodore Capital LP portfolio as well as his latest detailed transactions.

Portfolio value $1.12 Billion
Healthcare: $1.12 Billion

Stock Holdings Table Market Cap. of $2 Billions to $10 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 35
  • Current Value $1.12 Billion
  • Prior Value $1.16 Billion
  • Filing
  • Period Q2 2024
  • Filing Date August 14, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 5 stocks
  • Additional Purchases 15 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 5 stocks
Track This Portfolio

Track Commodore Capital LP Portfolio

Follow Commodore Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commodore Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Commodore Capital LP with notifications on news.